1. |
New therapy options for advanced colorectal cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
UK NICE guidance on GP IIb/IIIa receptor antagonists released |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
Show me the money - the tale of trastuzumab |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 6-7
Tracey Wright,
Preview
|
|
摘要:
Hot on the heels of positive clinical trial results for a new therapy come the requests for economic information. Decision-makers need such data to determine the potential economic impact of providing the new therapy to patients. This demand for economic data was the challenge facing economists at Hoffmann-La Roche in Canada after the presentation of phase III data for trastuzumab at the 1998 ASCO meeting.*To meet this demand, the company developed a model for predicting expenditures for adopting the new monoclonal antibody in the treatment of metastatic breast cancer. The model was presented at EORTC's 2nd European Conference on the Economics of Cancer [Brussels, Belgium; September 2000].*
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
Psychostimulant use: the good news and the bad news |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
HIV vaccines may lock the door to viral escape |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
News from ICAAC... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
Critical finger pointed at calcium antagonists |
|
Inpharma Weekly,
Volume &NA;,
Issue 1258,
2000,
Page 11-12
Ed Susman,
Preview
|
|
摘要:
An outspoken critic of calcium antagonists says that the drugs are not much better than other antihypertensives at controlling hypertension - and are associated with a higher incidence of myocardial infarction (MI) and heart failure, compared with therapies such as diuretics, ACE inhibitors and β-blockers. In a Hot Line oral presentation at the 22nd Congress of the European Society of Cardiology (ESC) [Amsterdam, The Netherlands; August 2000], Professor Curt Furberg from Wake Forest University School of Medicine, Winston-Salem, North Carolina, US, reported on a meta-analysis of 9 major trials in which calcium antagonists were compared with other treatments for hypertension.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|